Cardiolipin metabolism regulates expression of muscle transcription factor MyoD1 and muscle development
Journal of Biological Chemistry · 2023
DOI: 10.1016/j.jbc.2023.102978 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2023. Verfasst von Linh Vo und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Sciences, Wayne State University, Detroit, Michigan, USA. Hauptthemen laut MEDLINE: Barth Syndrome, Cardiolipins, MyoD Protein. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, NHLBI NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
The mitochondrial phospholipid cardiolipin (CL) is critical for numerous essential biological processes, including mitochondrial dynamics and energy metabolism. Mutations in the CL remodeling enzyme TAFAZZIN cause Barth syndrome, a life-threatening genetic disorder that results in severe physiological defects, including cardiomyopathy, skeletal myopathy, and neutropenia. To study the molecular mechanisms whereby CL deficiency leads to skeletal myopathy, we carried out transcriptomic analysis of the TAFAZZIN-knockout (TAZ-KO) mouse myoblast C2C12 cell line. Our data indicated that cardiac and muscle development pathways are highly decreased in TAZ-KO cells, consistent with a previous report of defective myogenesis in this cell line. Interestingly, the muscle transcription factor myoblast determination protein 1 (MyoD1) is significantly repressed in TAZ-KO cells and TAZ-KO mouse hearts. Exogenous expression of MyoD1 rescued the myogenesis defects previously observed in TAZ-KO cells. Our data suggest that MyoD1 repression is caused by upregulation of the MyoD1 negative regulator, homeobox protein Mohawk, and decreased Wnt signaling. Our findings reveal, for the first time, that CL metabolism regulates muscle differentiation through MyoD1 and identify the mechanism whereby MyoD1 is repressed in CL-deficient cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biological Sciences, Wayne State University, Detroit, Michigan, USA.
- Department of Anesthesiology, Perioperative Care, and Pain Medicine at New York University Grossman School of Medicine, New York, New York, USA; Department of Cell Biology at New York University Grossman School of Medic…
- Department of Biological Sciences, Wayne State University, Detroit, Michigan, USA. Electronic address: mgreenberg@wayne.edu.
Förderung
- NIGMS NIH HHS
- NHLBI NIH HHS
- National Institutes of Health
Zitieren
APA
Vo, L., Schmidtke, M. W., Da Rosa-Junior, N. T., Ren, M., Schlame, M., & Greenberg, M. L. (2023). Cardiolipin metabolism regulates expression of muscle transcription factor MyoD1 and muscle development. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2023.102978
Vancouver
Vo L, Schmidtke MW, Da Rosa-Junior NT, Ren M, Schlame M, Greenberg ML. Cardiolipin metabolism regulates expression of muscle transcription factor MyoD1 and muscle development. Journal of Biological Chemistry. 2023. doi:10.1016/j.jbc.2023.102978
BibTeX
@article{Vo2023,
author = {Vo, Linh and Schmidtke, Michael W and Da Rosa-Junior, Nevton T and Ren, Mindong and Schlame, Michael and Greenberg, Miriam L},
title = {Cardiolipin metabolism regulates expression of muscle transcription factor MyoD1 and muscle development},
journal = {Journal of Biological Chemistry},
year = {2023},
doi = {10.1016/j.jbc.2023.102978}
}
EUVIMED